Brady - New strategic plan, new sales expected FY20

Following its August trading update highlighting a slowdown in new sales, Brady's interim results were in line with our expectations. H119 revenue was £9.5m, a 9% fall vs H118, with an EBITDA loss of £1.8m and a PBT loss of £2.5m. Net cash fell to £1.0m from £4.6m at FY18. Recurring revenues represented 82% of total revenues. The new CEO has completed her strategic review and management is focused on delivering a more scalable, predictable and sustainable business to allow the company to become the leading independent E/CTRM vendor. The commodities sector remains attractive and as and when Brady demonstrates renewed sales momentum, it should become a compelling investment, currently trading on an FY19e EV/sales multiple of 1.1x.

Den vollständigen Artikel lesen ...